Guideline Adherence Impacts Mortality in Schizophrenia | News Brief

          0 votes

Adherence to the 2009 Schizophrenia Patient Outcomes Research Team (PORT) pharmacologic guidelines appears to help reduce mortality among patients with schizophrenia, according to a study from Johns Hopkins University. The authors recommend that clinicians consider adopting outcomes-monitoring systems and innovative service delivery programs to improve adherence to the PORT guidelines.

Abstract: Schizophrenia Bulletin, October 30, 2012 (online).

Please leave a comment

Your email address will not be published. Required fields are marked *

Search
Text Size
eMedia - Psychiatry
Alex__ButlerAlex__Butler: RT @andrewspong: Work in #pharma marketing? Follow the #VelocityDS feed this afternoon: http://t.co/vO9HE2SZ9d #hcmktg #socpharm
9 minutes ago
IgECPDIgECPD: RT @AllergyNet: Rare allergy to the outer layer of orange peel (the zest) MT @jacionline http://t.co/pycZqKi53F
27 minutes ago
IgECPDIgECPD: Mouth stings common in motorcyclists RT @AllergyNet: Fatal anaphylaxis while paragliding due 2 bee sting inside mouth http://t.co/5EjKBmHHTs
30 minutes ago
CosbyKid_FatDocCosbyKid_FatDoc: Hey, join the fastest growing health and fitness platform in North America. http://t.co/skWp2PDO33 I did!
1 hour ago
Facebook

 

 

 

Physician's Weekly for Current Medical News, Events & Issues